09:52 AM EST - Stellar Biotechnologies, Inc. : announced financial results for the first quarter period ended December 31, 2014. Revenues were $212,661, compared to $58,825 for the three months ended December 31, 2013. Net loss for the period was $1,343,477, or ($0.02) per basic share for the period ending December 31, 2014, compared to a net loss of $5,577,190, or ($0.08) per basic share, for the period ending December 31, 2013. Stellar Biotechnologies, Inc.
shares V.KLH are trading down $0.01 at $1.25.
